Treatable traits in the European U-BIOPRED adult asthma cohorts.
作者信息
Simpson Andrew J, Hekking Pieter-Paul, Shaw Dominick E, Fleming Louise J, Roberts Graham, Riley John H, Bates Stewart, Sousa Ana R, Bansal Aruna T, Pandis Ioannis, Sun Kai, Bakke Per S, Caruso Massimo, Dahlén Barbro, Dahlén Sven-Erik, Horvath Ildiko, Krug Norbert, Montuschi Paolo, Sandstrom Thomas, Singer Florian, Adcock Ian M, Wagers Scott S, Djukanovic Ratko, Chung Kian Fan, Sterk Peter J, Fowler Stephen J
机构信息
University of Manchester, and Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
Department of Sport, Health and Exercise Science, School of Life Sciences, The University of Hull, Hull, UK.
出版信息
Allergy. 2019 Feb;74(2):406-411. doi: 10.1111/all.13629. Epub 2018 Nov 12.
Abstract
摘要
相似文献
1
Treatable traits in the European U-BIOPRED adult asthma cohorts.欧洲U-BIOPRED成人哮喘队列中的可治疗特征。
Allergy. 2019 Feb;74(2):406-411. doi: 10.1111/all.13629. Epub 2018 Nov 12.
2
Treatable traits can be identified in a severe asthma registry and predict future exacerbations.可在严重哮喘登记处中识别可治疗的特征，并预测未来的加重。
Respirology. 2019 Jan;24(1):37-47. doi: 10.1111/resp.13389. Epub 2018 Sep 19.
3
Comorbid "treatable traits" in difficult asthma: Current evidence and clinical evaluation.难治性哮喘中的共病“可治疗特征”：当前证据和临床评估。
Allergy. 2018 Jul;73(7):1369-1382. doi: 10.1111/all.13370. Epub 2017 Dec 15.
4
Should we apply a treatable traits approach to asthma care?我们是否应该采用可治疗的特征方法来治疗哮喘？
Ann Allergy Asthma Immunol. 2022 Apr;128(4):390-397. doi: 10.1016/j.anai.2022.02.005. Epub 2022 Feb 13.
5
An update on asthma diagnosis.哮喘诊断的最新进展。
J Asthma. 2023 Dec;60(12):2104-2110. doi: 10.1080/02770903.2023.2228911. Epub 2023 Jul 2.
6
U.S. and European severe asthma cohorts: what can they teach us about severe asthma?美国和欧洲重症哮喘队列研究：它们能告诉我们哪些关于重症哮喘的信息？
J Intern Med. 2012 Aug;272(2):121-32. doi: 10.1111/j.1365-2796.2012.02558.x.
7
Difficult asthma.难治性哮喘
Allergy. 2003 Feb;58(2):114-21. doi: 10.1034/j.1398-9995.2003.02171.x.
8
Genetic analysis of quantitative traits in highly ascertained samples: total serum IgE in families with asthma.高度确定样本中数量性状的遗传分析：哮喘家庭中的总血清IgE
Genet Epidemiol. 2001;21 Suppl 1:S174-9. doi: 10.1002/gepi.2001.21.s1.s174.
9
The Brussels Declaration: the need for change in asthma management.《布鲁塞尔宣言》：哮喘管理变革的必要性。
Eur Respir J. 2008 Dec;32(6):1433-42. doi: 10.1183/09031936.00053108.
10
Asthma management in rural Australia.澳大利亚农村地区的哮喘管理。
Aust J Rural Health. 1999 Nov;7(4):249-52. doi: 10.1046/j.1440-1584.1999.00235.x.
引用本文的文献
1
Clinical importance of patient-reported outcome measures in severe asthma: results from U-BIOPRED.患者报告结局指标在重度哮喘中的临床重要性：U-BIOPRED研究结果
Health Qual Life Outcomes. 2024 Dec 20;22(1):109. doi: 10.1186/s12955-024-02321-3.
2
Molecular Pathways and Potential Therapeutic Targets of Refractory Asthma.难治性哮喘的分子途径及潜在治疗靶点
Biology (Basel). 2024 Aug 1;13(8):583. doi: 10.3390/biology13080583.
3
Change is in the air: key questions on the 'Treatable Traits' model for chronic airway diseases in primary care.变革在即：初级保健中慢性气道疾病“可治疗特征”模型的关键问题。
NPJ Prim Care Respir Med. 2024 Jul 18;34(1):21. doi: 10.1038/s41533-024-00381-y.
4
Systems Biology in Asthma.哮喘中的系统生物学。
Adv Exp Med Biol. 2023;1426:215-235. doi: 10.1007/978-3-031-32259-4_10.
5
Might It Be Appropriate to Anticipate the Use of Long-Acting Muscarinic Antagonists in Asthma?是否可以预期长效毒蕈碱拮抗剂在哮喘中的应用？
Drugs. 2023 Jul;83(11):957-965. doi: 10.1007/s40265-023-01897-2. Epub 2023 Jun 12.
6
Qualitative study of user perspectives and experiences of digital inhaler technology.定性研究用户对数字吸入器技术的看法和体验。
NPJ Prim Care Respir Med. 2022 Dec 22;32(1):57. doi: 10.1038/s41533-022-00320-9.
7
Influence of sex, cigarette smoking and airway inflammation on treatable traits in CBIOPRED severe asthma.性别、吸烟及气道炎症对CBIOPRED重度哮喘可治疗特征的影响
Clin Transl Allergy. 2022 Sep 15;12(9):e12189. doi: 10.1002/clt2.12189. eCollection 2022 Sep.
8
Evolving Concept of Severe Asthma: Transition From Diagnosis to Treatable Traits.重度哮喘的演变概念：从诊断到可治疗特征的转变
Allergy Asthma Immunol Res. 2022 Sep;14(5):447-464. doi: 10.4168/aair.2022.14.5.447.
9
Multimorbidity in Difficult Asthma: The Need for Personalised and Non-Pharmacological Approaches to Address a Difficult Breathing Syndrome.重度哮喘中的多种合并症：应对难治性呼吸综合征需要个性化和非药物治疗方法。
J Pers Med. 2022 Aug 31;12(9):1435. doi: 10.3390/jpm12091435.
10
Non-typeable airways infection: the next treatable trait in asthma?非典型气道感染：哮喘的下一个可治疗特征？
Eur Respir Rev. 2022 Sep 20;31(165). doi: 10.1183/16000617.0008-2022. Print 2022 Sep 30.
本文引用的文献
1
Comorbid "treatable traits" in difficult asthma: Current evidence and clinical evaluation.难治性哮喘中的共病“可治疗特征”：当前证据和临床评估。
Allergy. 2018 Jul;73(7):1369-1382. doi: 10.1111/all.13370. Epub 2017 Dec 15.
2
Precision medicine in airway diseases: moving to clinical practice.气道疾病精准医学：迈向临床实践。
Eur Respir J. 2017 Oct 19;50(4). doi: 10.1183/13993003.01655-2017. Print 2017 Oct.
3
After asthma: redefining airways diseases.哮喘之后：重新定义气道疾病。
Lancet. 2018 Jan 27;391(10118):350-400. doi: 10.1016/S0140-6736(17)30879-6. Epub 2017 Sep 11.
4
Trends in international asthma mortality: analysis of data from the WHO Mortality Database from 46 countries (1993-2012).国际哮喘死亡率趋势：对来自 46 个国家（1993-2012 年）的世卫组织死亡率数据库数据的分析。
Lancet. 2017 Sep 2;390(10098):935-945. doi: 10.1016/S0140-6736(17)31448-4. Epub 2017 Aug 7.
5
U-BIOPRED clinical adult asthma clusters linked to a subset of sputum omics.U-BIOPRED 临床成人哮喘聚类与痰液组学的一个子集相关。
J Allergy Clin Immunol. 2017 Jun;139(6):1797-1807. doi: 10.1016/j.jaci.2016.08.048. Epub 2016 Oct 20.
6
Treatable traits: toward precision medicine of chronic airway diseases.可治疗性状：迈向慢性气道疾病的精准医学。
Eur Respir J. 2016 Feb;47(2):410-9. doi: 10.1183/13993003.01359-2015.
7
Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort.欧洲 U-BIOPRED 成人严重哮喘队列的临床和炎症特征。
Eur Respir J. 2015 Nov;46(5):1308-21. doi: 10.1183/13993003.00779-2015. Epub 2015 Sep 10.
8
The mechanisms, diagnosis, and management of severe asthma in adults.成人重度哮喘的发病机制、诊断及管理
Lancet. 2006 Aug 26;368(9537):780-93. doi: 10.1016/S0140-6736(06)69288-X.
Zotero 插件